Literature DB >> 23449948

A comparative clinical evaluation of once daily versus alternate day application of topical clobetasol propionate cream in psoriasis.

Afroz Abidi1, Farida Ahmad, Satyendra K Singh.   

Abstract

BACKGROUND: Corticosteroids are extremely useful in the treatment of inflammatory skin disorders. Topical steroid applications are the most effective treatment for all types of psoriasis. AIMS: To compare the efficacy of once daily versus alternate day application of topical steroid clobetasol propionate 0.05% (Tenovate cream®) in patients who have mild to moderate plaque psoriasis. SETTINGS AND
DESIGN: This study was conducted on 89 patients of plaque psoriasis, who attended the skin OPD in our hospital. METHODS AND MATERIAL: The patients who had a mild to moderate severity of plaque psoriasis were selected. Those patients who required systemic corticosteroids, those who were already undergoing any psoriasis treatment, those who had any other debilitating illness and pregnant and lactating women were excluded from the study. Eighty nine patients were enrolled for the study after taking written informed consent from them and they were randomly allocated into two groups. Two patients dropped out, one in each group and 1 of group 2 was prescribed systemic corticosteroids.Group 1- once daily application (n= 44)Group 2- alternate day application (n= 42)An objective scoring was done on the basis of the PSI (Psoriasis Severity Index) score, which was graded from 0-4. Follow ups were done in the 2nd, 4th and 6th weeks. STATISTICAL ANALYSIS: It was done by the Student's 't' test and ANOVA. RESULTS AND
CONCLUSIONS: The results showed that there was equal improvement in both the groups in the 2nd week, since the p-value was not significant (P> 0.05), but in the 4th and 6th weeks, there was less improvement in the alternate day group (P< 0.05). An intra group comparison indicated that clobetasol was effective both in the once daily and the alternate day groups, but clinical and symptomatic improvement occurred more quickly in the once daily group after 6 weeks of assessment. Thus, it can be concluded that the alternate day application of the topical steroid clobetasol propionate cream is as effective as the once daily application in the initial 2 weeks, but by 6 weeks, its efficacy decreases. Therefore, initially, we can advocate a less frequent application of potent topical steroids but for the complete remission of the disease, the application frequency should be once daily.

Entities:  

Keywords:  Clobetasol propionate cream; PSI; Plaque psoriasis; Topical corticosteroid

Year:  2012        PMID: 23449948      PMCID: PMC3576762          DOI: 10.7860/JCDR/2012/4904.2681

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  EXISTENCE OF RESERVOIR IN THE STRATUM CORNEUM. EXPERIMENTAL PROOF.

Authors:  C F VICKERS
Journal:  Arch Dermatol       Date:  1963-07

2.  A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.

Authors:  J S English; C B Bunker; K Ruthven; P M Dowd; M W Greaves
Journal:  Clin Exp Dermatol       Date:  1989-01       Impact factor: 3.470

3.  Adverse effects of topical corticosteroids.

Authors:  G E Piérard; C Piérard-Franchimont; T Ben Mosbah; J Arrese Estrada
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

4.  Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").

Authors:  H Svartholm; L Larsson; B Frederiksen
Journal:  Curr Med Res Opin       Date:  1982       Impact factor: 2.580

5.  Partial mediation of glucocorticoid antiproliferative effects by lipocortins.

Authors:  W Y Almawi; M S Saouda; A C Stevens; M L Lipman; C M Barth; T B Strom
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

6.  Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids.

Authors:  A Bewley
Journal:  Br J Dermatol       Date:  2008-02-22       Impact factor: 9.302

7.  Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application.

Authors:  D Lubach; J Rath; M Kietzmann
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

8.  Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment.

Authors:  S S Bleehen; A C Chu; I Hamann; C Holden; J A Hunter; R Marks
Journal:  Br J Dermatol       Date:  1995-10       Impact factor: 9.302

9.  Glucocorticoids inhibit apoptosis of human neutrophils.

Authors:  W C Liles; D C Dale; S J Klebanoff
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

10.  Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.

Authors:  Afroz Abidi; Farida Ahmad; Satyendra K Singh; Anil Kumar
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

View more
  1 in total

1.  PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.

Authors:  Linda Stein Gold; Javier Alonso-Llamazares; Jean-Philippe Lacour; Richard B Warren; Stephen K Tyring; Leon Kircik; Paul Yamauchi; Mark Lebwohl
Journal:  Adv Ther       Date:  2020-09-23       Impact factor: 3.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.